Previous 10 | Next 10 |
WOBURN, Mass., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company recently filed a request for a Regulatory Status Review (“RSR”) with...
2024-01-01 08:00:02 ET Summary In 2023, across two accounts, my portfolios returned +98.4%. In the flagship account, my four-year CAGR (pre-tax), from January 1, 2020 - December 31, 2023, was 46%. This piece discusses what did and didn't work in 2023. What a differen...
2023-12-04 16:40:15 ET Summary The Flagship Account and Smaller Managed Account have performed well year-to-date through November 30, 2023. The blended total return is +71% vs. 4.2% for the Russell 2000. Per Pernas Research, from January 1, 2020 - November 20, 2023, 40.5% of stock...
WOBURN, Mass., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the U.S. Department of Agriculture Animal & Plant Health Inspection Service’s (...
-Yield10 Achieves a Significant Milestone in the Development of Camelina as a Commercial Crop for Producing Biofuels and Omega-3 Oils -On Track for Commercial Launch of Glufosinate Tolerant Camelina as early as 2025 WOBURN, Mass., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Yield10 Biosci...
2023-11-14 21:57:09 ET Yield10 Bioscience, Inc. (YTEN) Q3 2023 Earnings Conference Call November 14, 2023 16:30 ET Company Participants Lynne Brum - Investor Relations Oliver Peoples - President and Chief Executive Officer Kristi Snell - Vice President, Research ...
2023-11-14 16:03:55 ET More on Yield10 Bioscience Courage & Conviction Investing On Farmer Bros, Red Robin And Yield10 Bioscience 'Stay Hungry, Stay Foolish' Small Cap Strategies With Courage & Conviction Investing Yield10 Bioscience Q3 2023 Earnings Preview ...
-Establishes "Camelina Seed Genetics to Biofuel" Platform -Advances Herbicide Tolerant Camelina Varieties toward Commercialization -Exercises Option to Finalize Exclusive, Global Commercial License to Advanced Omega-3 Technology -Management will host a conference call today at 4...
Laser Photonics Corporation (LASE) is expected to report for Q2 2024 QuickLogic Corporation (QUIK) is expected to report $0.08 for Q3 2023 Stryve Foods Inc. (SNAX) is expected to report $-1.65 for Q3 2023 Reata Pharmaceuticals Inc. (RETA) is expected to report $-2.15 for Q3 2023 V...
Yield10 Bioscience Inc. (YTEN) is expected to report $-0.31 for Q3 2023
News, Short Squeeze, Breakout and More Instantly...
Yield10 Bioscience Inc. Company Name:
YTEN Stock Symbol:
NASDAQ Market:
- Nufarm to pay up to USD $5 million in consideration for the license -The parties will negotiate the sale of essentially all of Yield10’s assets to Nufarm WOBURN, Mass. and WEST SACRAMENTO, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“...
WOBURN, Mass. and HARPENDEN, United Kingdom, June 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that U.K.-based Rothamsted Research Limited (“Rothamsted”)...
- EPA approved an amendment to the label of INTERLINE herbicide to include Camelina -The supplemental label now allows application of INTERLINE for over-the-top weed control in Camelina WOBURN, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield1...